| mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
-0.0077 |
0.8 |
| mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
0.0074 |
0.8 |
| mRNA |
BRD-K26531177 |
CTRPv2 |
pan-cancer |
AAC |
0.0074 |
0.8 |
| mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
0.0069 |
0.8 |
| mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
-0.0065 |
0.9 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0066 |
0.9 |
| mRNA |
SKI-II |
CTRPv2 |
pan-cancer |
AAC |
-0.007 |
0.9 |
| mRNA |
IPA-3 |
GDSC1000 |
pan-cancer |
AAC |
-0.0064 |
0.9 |
| mRNA |
Sildenafil |
CTRPv2 |
pan-cancer |
AAC |
0.0069 |
0.9 |
| mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0061 |
0.9 |